Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis
NCT01282905 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106
Last updated 2011-01-26
Summary
The purpose of this study is to evaluate the relation between sulphide detoxification and butyrate metabolism at the level of gene expression and enzyme activity in ulcerative colitis patients and healthy controls.
Conditions
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Principal Investigators
-
Kristin Verbeke, PhD · KU Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-10-31
- Completion
- 2010-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
NCT02463305 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
NCT06294925 ·Status: RECRUITING
-
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
NCT03934216 ·Status: COMPLETED ·Phase: PHASE2
-
Restoration of the Microbiome Through Superdonor Selection
NCT03110289 ·Status: UNKNOWN ·Phase: NA
-
A Study of Abatacept in Patients With Active Ulcerative Colitis
NCT00410410 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis
NCT01216280 ·Status: UNKNOWN ·Phase: PHASE2
-
Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
NCT04000139 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis
NCT01097590 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
NCT02762500 ·Status: COMPLETED ·Phase: PHASE2
-
Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis
NCT04926103 ·Status: RECRUITING ·Phase: NA
-
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
NCT06298461 ·Status: RECRUITING ·Phase: PHASE4
-
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
NCT02438410 ·Status: COMPLETED
-
Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis
NCT02888379 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolomic Markers of Fatigue in Inflammatory Bowel Disease
NCT04191707 ·Status: COMPLETED
-
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
NCT00694980 ·Status: COMPLETED ·Phase: PHASE1
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
NCT02958865 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
NCT02840721 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis
NCT03849599 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function
NCT04508413 ·Status: COMPLETED ·Phase: NA
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
NCT01961492 ·Status: WITHDRAWN ·Phase: NA
-
The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD
NCT07257588 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
TUDCA as a Therapy for Ulcerative Colitis (UC)
NCT04114292 ·Status: COMPLETED ·Phase: PHASE1